New Omicron subvariant largely evades neutralizing antibodies

A study at Karolinska Institutet in Sweden shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several...

Paxlovid, Pfizer’s oral COVID-19 pill, approved in Canada - National | Globalnews.ca

Pfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.

How Omicron spreads so fast is the question of the moment. New research is pointing to the answer |...

New research from a team in Hong Kong offers a clue to why the Omicron variant is spreading so astonishingly fast around the world: it may be multiplying 70 times quicker than earlier strains within...

Longer gaps between mRNA vaccine doses give stronger immune response: Canadian study | Globalnews.ca

The study of 186 paramedics across Canada is the first of its kind in North America, and found waiting between mRNA vaccine doses leads to higher antibody concentrations.

Vancouver-area health officials train dog team to sniff out COVID-19

A health authority with a history of using dogs to help detect medical conditions has found a way to use its canine scent detection team to sniff out COVID-19.

The lambda COVID-19 variant is now spreading in Canada — here's what you need to know | CBC News

Multiple variants of the virus behind COVID-19 are circulating in Canada, and lambda has now joined their ranks, with 11 cases reported across the country so far.

Feeling bad after a second COVID-19 vaccine dose? Here’s why that should buy you some peace of mind

The second dose will help prime the immune system, which explains all those symptoms

AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms in large trial - National |...

AstraZeneca said a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease.

COVID-19: Vaccine hesitancy on the decline in Canada and B.C., polls

Race between vaccines and variants is back on as B.1.617 takes hold in Canada

A new variant is taking hold in Canada, but our vaccine supply is ramping and second doses are accelerating across the country. So how at risk are we from B.1.617, and how concerned should Canadians...

'Remarkable': Non-COVID respiratory illness plummeted during pandemic, Alberta study finds